Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories hits 52-week low as its consolidated net profit drops 69% in Q1

Consolidated total income of the company declined by 4.60% to Rs 8,454.50 crore in Q1FY27

Dr. Reddy's Laboratories’ consolidated net profit drops 69% in Q1

Consolidated total income of the company declined by 4.60% to Rs 8,454.50 crore in Q1FY27

Dr. Reddy’s Laboratories informs about audio recordings of earnings call

Dr. Reddy’s Laboratories informs about audio recording of conference call

Dr. Reddy’s Laboratories informs about analyst meet

Dr Reddys Laboratories informs about AGM

Dr. Reddy's Laboratories launches generic Semaglutide Injection in Canada

The company’s Semaglutide Injection is indicated for the once-weekly treatment of adults with type 2 diabetes mellitus

Dr. Reddy’s Laboratories informs about press release

Dr. Reddy's Laboratories reports 86% plunge in Q4FY26 consolidated net profit

Consolidated total income of the company decreased by 11.37% at Rs 8,021.80 crore for Q4FY26

Dr. Reddy's Lab reports Profit after tax of Rs -2194.00 Mln, in the March 2026 quarter